Anji Pharma, a biotech with outposts in China and the U.S., has raised $70 million to continue clinical development of two metabolic disorder drugs and begin work on an oncology pipeline. The cash ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anji Pharmaceuticals, Inc. (“Anji” or “the Company”) today announced the acquisition of global development rights for a novel delayed-release formulation of ...
CAMBRIDGE, Mass. & SHANGHAI--(BUSINESS WIRE)--Anji Pharma (“Anji”) has initiated a pivotal trial of ANJ900 (delayed-release metformin) in patients with Type 2 diabetes (T2D), including those with ...
Please provide your email address to receive an email when new articles are posted on . Anji Pharmaceuticals and Population Health Partners announced a strategic collaboration to accelerate the ...
Amphastar Pharmaceuticals has signed an exclusive licence agreement with Nanjing Anji Biotechnology, focusing on the development, production, use and commercialisation of three peptides in the US and ...
Pradigastat is a well-characterized molecule which has progressed to Phase 3 clinical testing. Anji has secured rights to pursue new indications for pradigastat, with an initial focus on regulatory ...
Arc System Works revealed Guilty Gear Strive Anji Mito’s reworked fighting style in a brand new trailer. The company teased the video on YouTube several days earlier via a premier. Arc System Works ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback